Trans-resveratrol and pterostilbene are structurally related polyphenols, both studied as sirtuin-activating compounds with antioxidant properties, but they differ meaningfully in bioavailability and depth of human research. Pterostilbene has two methoxy groups in place of resveratrol's hydroxyl groups, a small structural difference that improves oral bioavailability and half-life. Resveratrol, meanwhile, has a much longer and deeper human clinical trial history across a wider range of applications.
Quick Facts
- Better oral bioavailability: Pterostilbene
- Deeper human trial history: Trans-resveratrol
- Shared mechanism: Sirtuin activation, antioxidant activity
- Typical resveratrol dose: 150-500mg/day in trials
- Typical pterostilbene dose: 100-250mg/day in trials
The Structural Difference That Matters
Pterostilbene's two methoxy groups, in place of resveratrol's hydroxyl groups, make it more lipophilic (fat-soluble), improving how well it's absorbed orally and how long it stays active in the body before being metabolized and cleared. This is a genuine pharmacokinetic advantage, meaning a given dose of pterostilbene may produce more consistent blood levels than an equivalent dose of resveratrol, which is notoriously rapidly metabolized in the body.
Trans-Resveratrol: The Deeper Trial History
Resveratrol has been studied far more extensively in human trials, across applications including cardiovascular markers, metabolic health, and, in combination with NAD+ precursors, longevity-adjacent research. Despite its rapid metabolism, this substantial body of human research gives it a more established evidence base overall, even if any single dose doesn't stay in circulation as long as pterostilbene. See our full Trans-Resveratrol guide.
Pterostilbene: Better Pharmacokinetics, Smaller Trial Base
Pterostilbene's improved bioavailability is well documented, but its standalone human trial base, while growing, remains smaller than resveratrol's. Some research has specifically combined the two compounds (as NRPT, alongside nicotinamide riboside), rather than treating pterostilbene purely as a resveratrol substitute. See our full Pterostilbene guide.
What the Research Actually Shows
Resveratrol's broader trial base. Evidence level: Established for bioavailability and safety; mixed for specific downstream health outcomes. Cardiovascular and metabolic marker studies show mixed results depending on dose, formulation, and population studied.
Pterostilbene's bioavailability advantage. Evidence level: Established. Pharmacokinetic studies consistently confirm improved absorption and half-life compared to resveratrol.
Combined NR plus pterostilbene. Evidence level: Promising. An early combination trial found this pairing safely and sustainably raised NAD+ levels in humans.
Which Should You Choose?
If consistent blood levels and convenient dosing matter most to you, pterostilbene's pharmacokinetic advantage is relevant. If you prioritize the depth and breadth of existing human trial data across a wider range of applications, resveratrol remains the more extensively studied option. Some longevity-focused protocols use both, given their related but not identical properties.
Safety & Who Should Be Cautious
Both compounds have generally favorable safety profiles at studied doses. Both can interact with blood-thinning medication at higher doses, given their effects on platelet function, so anyone on anticoagulants or antiplatelet medication should consult a healthcare provider before starting either.
ⓘ Pterostilbene has the pharmacokinetic edge; resveratrol has the deeper trial history. Neither is a clear universal winner over the other.
Frequently Asked Questions
Is pterostilbene better absorbed than resveratrol?
Yes, pterostilbene's structural difference makes it more lipophilic, improving oral bioavailability and how long it remains active in the body compared to resveratrol.
Does resveratrol's rapid metabolism make it less useful?
Not necessarily; despite rapid metabolism, resveratrol has a much larger and longer human clinical trial history across various applications than pterostilbene.
Can I take resveratrol and pterostilbene together?
Yes, some research has combined pterostilbene with related compounds like nicotinamide riboside, and there's no known negative interaction between resveratrol and pterostilbene themselves.
Which has more human research behind it?
Resveratrol has a substantially larger body of human clinical research across a broader range of applications, even though pterostilbene has the pharmacokinetic advantage.
Are there safety concerns with either compound?
Both can interact with blood-thinning medication at higher doses. Anyone on anticoagulants should consult a healthcare provider before starting either.
Scientific References
- Dellinger, R. W., Santos, S. R., Morris, M., et al. "Repeat Dose NRPT (Nicotinamide Riboside and Pterostilbene) Increases NAD+ Levels in Humans Safely and Sustainably." NPJ Aging and Mechanisms of Disease, 2017;3:17.
- Riche, D. M., McEwen, C. L., Riche, K. D., et al. "Analysis of Safety from a Human Clinical Trial with Pterostilbene." Journal of Toxicology, 2013;2013:463595.
Disclaimer
This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you are taking blood-thinning medication.
